T. Inaba

6.1k citations
122 papers · 5.2k · 1 hit paper · h-index 37

Impact in

  • Pharmacology top 0.02%
    • Pharmacogenetics and Drug Metabolism
    • Drug-Induced Hepatotoxicity and Protection
  • Toxicology top 0.1%
    • Forensic Toxicology and Drug Analysis

Papers in

T. Inaba

120 papers receiving 5.0k citations

T. Inaba's Hit Papers

Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver 1989 · 435 citations
4350+12+24Years since publication100200300400

Peers

T. Inaba
Comparison fields: 5 of 132
  • Pharmacology 2.6k
  • Toxicology 520
  • Pharmacology 806
  • Oncology 1.2k
  • Clinical Biochemistry 293
Replace Geoffrey T. Tucker with:
Geoffrey T. Tucker United Kingdom
W. Kalow Canada
M. S. Lennard United Kingdom
Juliette Säwe Sweden
Takashi Ishizaki Japan
Thomas A. Baillie United States
Kim Brøsen Denmark
Felix Bochner Australia
Chin B. Eap Switzerland
Stephan Krähenbühl Switzerland
T. Inaba relative to Geoffrey T. Tucker United Kingdom Geoffrey T. Tucker's profile →
Citations per field
00.5×1.5×
Geoffrey T. Tucker · 1×
Citations per year

Countries citing papers authored by T. Inaba

Since Specialization
Citations

This map shows the geographic impact of T. Inaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Inaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Inaba more than expected).

Fields of papers citing papers by T. Inaba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Inaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Inaba. The network helps show where T. Inaba may publish in the future.

Co-authors

The 25 scholars most cited alongside T. Inaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with T. Inaba Line = papers co-authored together T. Inaba links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 122 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Cytochrome P-450 hPCN3, a Novel Cytochrome P-450 IIIA Gene Product That Is Differentially Expressed in Adult Human Liver
Hit paper breakdown →
1989435
2 1979227
3 1978205
4 1977195
5 1987192
6 1996189
7 1984172
8 1985166
9 2002156
10 1994140
11 1989136
12 1997134
13 1991121
14 1991103
15 1985101
16 199194
17 199191
18 199385
19 198975
20 199974

About T. Inaba

T. Inaba is a scholar working on Pharmacology, Molecular Biology, Oncology, Clinical Biochemistry and Spectroscopy, having authored 122 papers that have together received 5.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (45 papers), Drug Transport and Resistance Mechanisms (24 papers), Metabolism and Genetic Disorders (23 papers), Analytical Chemistry and Chromatography (14 papers), Pharmacological Effects and Toxicity Studies (12 papers), Botanical Research and Chemistry (11 papers), Plant-based Medicinal Research (10 papers) and Eicosanoids and Hypertension Pharmacology (8 papers). The work is most often cited by research in Pharmacology (2.6k citations), Toxicology (520 citations), Pharmacology (806 citations), Oncology (1.2k citations) and Clinical Biochemistry (293 citations). T. Inaba has collaborated with scholars based in Canada, Japan and United States. Frequent co-authors include W. Kalow, S V Otton, W Kalow, Rachel F. Tyndale, David J. Stewart, M Jurima, Frank J. Gonzalez, Edward M. Sellers, Urs Meyer and Harry V. Gelboin. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Drug Metabolism and Disposition, Canadian Journal of Physiology and Pharmacology, British Journal of Clinical Pharmacology and Life Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact